Precise radiotherapy ndiyo inonyanya kukosha nzira yekurapa cancer. Chaiyo radiotherapy matekiniki anomiririrwa nekukurumidza kumberi banga, proton banga, inorema ion, nezvimwewo, inogona kuvhiya zvakanyanya uye kurapa kwekubatsira kune varwere vegomarara. To understand the progress of radiotherapy, sarcoma is more common in young people, is a malignant tumor derived from mesenchymal tissue (including connective tissue and muscle). Sarcomas are highly malignant and develop rapidly! Common scomcom include osteosarcoma, leiomyoma, lymphosarcoma, synovial sarcoma, etc.
Nzira yakasarudzwa ye sarcoma kuvhiyiwa. Kuti vatsvage kurapwa, vanachiremba vemudzimba vanowanzoda kuti varwere vadimburwe makumbo nemaoko. , Varwere vakawanda vanonetsa kurapa. Sarcoma haina hanya nekemotherapy. Radiotherapy radiotherapy zvakare yakaoma kuuraya mamota, uye leiomyoma, lymphosarcoma, uye synovial sarcoma inokanganisa metastasis kuburikidza neropa. Naizvozvo, kurapwa kwesarcoma kunofanirwa kuve nekukurumidza uye nekukurumidza sezvazvinogona.
The EDGE Radiosurgery system (EDGE radiosurgery tumarara treatment system) was developed by the American Varian company and was approved by the US FDA on January 23, 2013. The EDGE blade is by far the most effective non-invasive tumor removal technology, using the unique FDA’s Calypso® GPS for the Body® system and surface beam monitoring system approved on July 21, 2014 with high-frequency real-time dynamics of up to 10 ms Monitor and lock the tumor “escape” during the treatment process, combined with the new generation IGRT and other image guidance technology, using the unique high-intensity HD-MLC collimator up to 2400MU / min to remove tumor tissue with sub-millimeter accuracy with almost no residue .
Iwo akasarudzika maitiro eEDGE yekumhanyisa banga, yakakwira-yakasimba mwaranzi inosvika 2400MU / min, inogona kukurumidza kutyora DNA yemaseru ebundu, uye pakupedzisira kuita kuti masero ebundu afe, uye bundu rinonyudzwa kana vanga. Kururamisa kweiyo banga reEGEGE kwakakwirira se0.1mm.
